First drug approval for injection-lipolysis in USA
Under the trademark Kybella (TM) the company Kythera has received the FDA approval for double chin....more
THE FUTURE OF INJECTION-LIPOLYSIS / LIPODISSOLVE
10 years NETWORK-Lipolysis - commentary of NETWORK speaker Dirk Brandl...
Happy New Year 2014 to all members and friends of the NETWORK
Every week new articles and publications about Injection-Lipolysis/Lipodissolve
Nearly every week new articles are published in medical journals...
American Study Proves Efficacy and Safety of PC-DC Injections
For the first time, the results which have now been published in the renowned Aesthetic Surgery Journal (ASJ) of a study by American doctors that was commissioned by the ASAPS (American Society of Aesthetic Plastic Surgery) and approved by the FDA (Federal Drug Administration) confirm the efficacy and low risk of injection lipolysis treatment.
Next Training May 4, 2013 in London
For further information please contact Anna +49-2508-2159-201 or write an email ...more
Switzerland: Injection lipolysis now legal as a formula magistralis
Medical law expert Prof. Poledna achieves success jointly with the NETWORK...more
A brief review...
The speakers of this year's event
Aesthetic Holidays 2012
A brief assessment...more
MASTER-Conference 2012 Majorca
Hot news about injection lipolysis and mesotherapy June 11...
Publications 2 - Ruhr University Bochum - Lipoma
Recurrent growth of lipomas after previous treatment with phosphatidylcholine and deoxycholate...more
International Aesthetic Holidays and MASTER-Conference 2012
June 11-14, 2012
Chinese delegation visits the NETWORK
On 8 November, we were able to welcome a delegation from the People’s Republic of China ...
Situation of Injection Lipolysis after the withdrawal of Lipostabil from the market
NETWORK Director Dr. Franz Hasengschwandtner comments on and assesses the current situation....
NETWOK members give preliminary assessment of ATX-101
Members of our Scientific und Medical Advisory Boards have given their first assessment regarding the product ATX-101 (Kythera-Intendis)....
Programme 2012 Globalhealth Academy
In 2012, the Globalhealth Academy will offer a comprehensive programme of training in all important minimally invasive therapies...
ATX-101 - New lipolysis drug in Phase 3 multicentre study
The American start-up Kythera Inc. and BAYER subsidiary Intendis cooperating on licensing of ATX-101....
Publications 1 - Garsing Wong et al.
With the introduction of this new feature we would like to inform our readers about actual injection-lipolysis publications....
France: Return to common sense
The controversial decree by the French health authorities banning all minimally invasive therapies for fat reduction has been revoked....
Aesthetic Holidays 2011 Mallorca 23-26. June: a super event
More than 60 participants took advantage of the opportunity to gather and discuss in a relaxed atmosphere....
Complete group practices among those attending
France: ......calling from middle ages........
Dear Members and Friends of NETWORK-Globalhealth,
A cry for help has reached us from our colleagues in France, where a ministerial decree came into force 2 weeks ago which constitutes a massive restriction on medical freedom and which we wish to inform you about by this letter. The letter from our French colleagues is ....
Lipolysis: Lipostabil N no longer available on the market
NETWORK members have alternative treatment options....more
Workshop in Beijing
Dr. Justin Hao, certified NETWORK trainer presented Lipolysis and more to 50 physicians of P.R. China.....
Doublechin treatment during the workshop
Aesthetic Holidays 2011
Aesthetic Holidays 2011 Sharm El-Sheikh cancelled....more
The University of Florence has published a study of the treatment of buffalo hump on HIV patients
The study has been published in the January issue of the Journal of Plastic, Reconstructive & Aesthetic Surgery...more